Dr. Zhijian Li | Clinical Pharmacy

🎉🏆 Congratulations, Dr. Zhijian Li , on Your Outstanding Achievement as the Best Researcher! 🏆🎉
Dr. Zhijian Li : Leading Researcher in Clinical Pharmacy

University Professor at Clinical Pharmacy, Beijing University of Chinese Medicine, China

Your remarkable academic journey, extensive research contributions, and dedication to the field of psychology are truly commendable. Your wealth of knowledge and diverse skill set reflect a deep commitment to understanding and addressing critical issues such as bullying, inclusion, and socialization.

🔬 Your successful completion of a PhD in Psychology, along with the numerous advanced courses and workshops, showcases your continuous pursuit of excellence and expertise in your field.

🏆 The awards and recognitions, including the First Place in the Poster Award at the University of Stavanger, underscore the impact of your research and the high regard it holds in the academic community.

Professional Profiles:

Education:

He earned my Bachelor of Science (B.S.) in Chinese Pharmacy from Beijing University of Chinese Medicine, completing the program from 2002 to 2006. Subsequently, He pursued my Master’s degree in Clinical Chinese Pharmacy at the same institution from 2006 to 2009. During this period, He had the privilege of being supervised by Professor Bing Zhang. Continuing my academic journey, He went on to achieve a Ph.D. in Research on the Therapeutic Mechanism of Chinese Medicine for Hyperuricemia from Beijing University of Chinese Medicine, under the guidance of Professor Bing Zhang, completing the program from 2009 to 2012. These educational experiences have equipped me with a comprehensive understanding of Chinese Pharmacy and an in-depth exploration of therapeutic mechanisms in the realm of Chinese Medicine.

Employment:

Since 2012, He have been contributing to the academic community as a Lecturer in Chinese Pharmacy within the School of Chinese Pharmacy at Beijing University of Chinese Medicine. In recognition of my dedication and contributions to the field, He was honored with the title of Associate Professor in December 2015. In this capacity, my primary responsibilities encompass both teaching and research in the field of clinical Chinese pharmacy. This multifaceted role has allowed me to impart knowledge to students while actively engaging in research endeavors, thereby fostering a comprehensive understanding of the discipline.

Teaching Interests:

His teaching endeavors reflect a profound passion for Clinical Chinese Pharmacy, serving as my primary area of interest. Beyond this, He also enthusiastic about incorporating technology to enhance the teaching and learning experience. These dual interests underscore my commitment to delivering education in a dynamic and effective manner.

His dedication to innovative teaching methodologies has garnered notable recognition. In the National Competition of Basic Teaching Skills of Traditional Chinese Medicine (TCM) in 2017, His was honored with the Third Prize, a testament to my proficiency in imparting essential skills. Furthermore, my efforts in advancing education through Massive Open Online Courses (MOOCs) were acknowledged by the Chinese Medical Association in 2016, where He received the First Prize, shared with colleagues at Beijing University of Chinese Medicine (BUCM).

Publications:

Are hyperuricemia and gout different diseases? Comment on the guidelines for the diagnosis and management of hyperuricemia and gout with the healthcare professional perspectives in China

  • Published in Energy in 2023 with 1 citations.

In Vitro and In Silico Anti-Rheumatic Arthritis Activity of Nyctanthes arbor-tristis

  • Published in Energy in 2023 with 2 citations.

Global status and trends in gout research from 2012 to 2021: a bibliometric and visual analysis

  • Published in Energy in 2023 with 0 citations.

Rutin ameliorates gout via reducing XOD activity, inhibiting ROS production and NLRP3 inflammasome activation in quail

  • Published in Energy in 2023 with 9 citations.

A bibliometric analysis of research progress on pharmacovigilance and cancer from 2002 to 2021

  • Published in Energy in 2023 with 2 citations.